|
|
|||
|
||||
OverviewThis book provides medical technology entrepreneurs and their investors with a decision-making methodology based on the scientific approach that maximizes their chances of success. It enriches the understanding of valuation for medical startups, proposing an approach that moves the focus from the sophistication of the forecasting and financial methodologies to the quantitative importance of high-quality business assumptions and the economic impact of each critical business decision. It also provides a complete set of visual, organized, and compelling mental maps tailored to the business of medical technology innovation; maps that visualize and link the medical venture’s decision-making and prediction problems. Their use minimizes the probability of overlooking critical decision problems on the path to successful execution while connecting them through a sequential and hierarchical framework. Finally, the book provides practical, real-life examples of how the scientific approach to decision-making can be used in medical technology startups outside the clinical trial area. The reader is left with various sets of valuable and practical tools that can be individually applied. Full Product DetailsAuthor: Luigi NegriPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG ISBN: 9783032150066ISBN 10: 303215006 Pages: 239 Publication Date: 22 February 2026 Audience: General/trade , General Format: Hardback Publisher's Status: Forthcoming Availability: Not yet available This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of ContentsChapter 1:Introduction.- Chapter 2:The Vocabulary of Medical Ventures.- Chapter 3:Why Medical Innovation is so Difficult.- Chapter 4:Minimizing Decision-Making Biases.- Chapter 5:Decision-Making Using a Scientific Approach.- Chapter 6:Mapping Decision-Related Problems in Medical Innovations.- Chapter 7:Deep-Dive into the Mapping of Decision-Related Problems.- Chapter 8:Prioritizing Decision-Related Problems.ReviewsAuthor InformationDr Luigi Negri is Founder and CEO for ThinKeen® Global Consulting (Miami, FL, USA) and Venture Partner of Obloo® Ventures Consulting (Milano, Italy). In this role, he has supported investors in the appraisal and valuation of target medical startups, he has been a board member of highly innovative medical startups and served as a member of advisory boards of broader public initiatives focused on evaluating larger populations of life science startups. In the previous twenty years, Luigi has succeeded as an executive in several international corporate assignments with general management responsibilities in the biotechnology and medical devices industry across multiple global corporations and geographical regions. These positions included VP of Northern & Central Europe for Becton Dickinson® (CR Bard), VP of Emerging Markets of Latin America at Baxter Health Care, and Area General Manager for Poland & Russian Federation at Baxter Health Care®. Tab Content 6Author Website:Countries AvailableAll regions |
||||